INTRODUCTION: Posttraumatic venous thromboembolism (VTE) remains prevalent in severely injured patients despite chemoprophylaxis. Importantly, although platelets are central to thrombosis, they are not routinely targeted in prevention of posttraumatic VTE. Further, platelets from injured patients show ex-vivo evidence of increased activation yet impaired aggregation, consistent with functional exhaustion. However, the relationship of this platelet functional phenotype with development of posttraumatic VTE is unknown. We hypothesized that following injury impaired ex-vivo platelet aggregation (PA) is associated with the development of posttraumatic VTE. METHODS: We performed a secondary analysis of 133 severely injured patients from a prospective observational study investigating coagulation and inflammation (2011-2019). PA in response to stimulation with adenosine diphosphate (ADP), collagen, and thrombin was measured at presentation (pre-resuscitation) and 24 h (post-resuscitation). Viscoelastic clot strength and lysis were measured in parallel by thromboelastography. Multivariable regression examined relationships between PA at presentation, 24 h, and the delta between presentation and 24 h with development of VTE. RESULTS: The 133 patients were severely injured (median injury severity score 25) and 14% developed VTE (all >48 hours after admission). At presentation, platelet count and PA were not significantly different between those with and without incident VTE. However, at 24 h, those who subsequently developed VTE had significantly lower platelet counts (126 x109/L vs 164 x109/L, p = 0.01), and lower PA in response to ADP (p < 0.05), collagen (p < 0.05), and thrombin (p = 0.06). Importantly, the magnitude of decrease in PA (Delta) from presentation to 24 h was independently associated with development of VTE (adjusted odds ratios per 10 aggregation unit decrease: Delta-ADP 1.31, p = 0.03; Delta-collagen 1.36, p = 0.01, Delta-thrombin 1.41, p < 0.01). CONCLUSION: Severely injured patients with decreasing ex-vivo measures of platelet aggregation despite resuscitation have an increased risk of developing VTE. This may have implications for predicting development of VTE and for studying platelet targeted chemoprophylaxis regimens. LEVEL OF EVIDENCE: level III, prognostic.
INTRODUCTION: Posttraumatic venous thromboembolism (VTE) remains prevalent in severely injured patients despite chemoprophylaxis. Importantly, although platelets are central to thrombosis, they are not routinely targeted in prevention of posttraumatic VTE. Further, platelets from injured patients show ex-vivo evidence of increased activation yet impaired aggregation, consistent with functional exhaustion. However, the relationship of this platelet functional phenotype with development of posttraumatic VTE is unknown. We hypothesized that following injury impaired ex-vivo platelet aggregation (PA) is associated with the development of posttraumatic VTE. METHODS: We performed a secondary analysis of 133 severely injured patients from a prospective observational study investigating coagulation and inflammation (2011-2019). PA in response to stimulation with adenosine diphosphate (ADP), collagen, and thrombin was measured at presentation (pre-resuscitation) and 24 h (post-resuscitation). Viscoelastic clot strength and lysis were measured in parallel by thromboelastography. Multivariable regression examined relationships between PA at presentation, 24 h, and the delta between presentation and 24 h with development of VTE. RESULTS: The 133 patients were severely injured (median injury severity score 25) and 14% developed VTE (all >48 hours after admission). At presentation, platelet count and PA were not significantly different between those with and without incident VTE. However, at 24 h, those who subsequently developed VTE had significantly lower platelet counts (126 x109/L vs 164 x109/L, p = 0.01), and lower PA in response to ADP (p < 0.05), collagen (p < 0.05), and thrombin (p = 0.06). Importantly, the magnitude of decrease in PA (Delta) from presentation to 24 h was independently associated with development of VTE (adjusted odds ratios per 10 aggregation unit decrease: Delta-ADP 1.31, p = 0.03; Delta-collagen 1.36, p = 0.01, Delta-thrombin 1.41, p < 0.01). CONCLUSION: Severely injured patients with decreasing ex-vivo measures of platelet aggregation despite resuscitation have an increased risk of developing VTE. This may have implications for predicting development of VTE and for studying platelet targeted chemoprophylaxis regimens. LEVEL OF EVIDENCE: level III, prognostic.
Authors: Christopher C Verni; Antonio Davila; Steve Balian; Carrie A Sims; Scott L Diamond Journal: J Trauma Acute Care Surg Date: 2019-02 Impact factor: 3.313
Authors: Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal Journal: J Thromb Haemost Date: 2019-07-28 Impact factor: 5.824
Authors: Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores Journal: Chest Date: 2016-01-07 Impact factor: 9.410
Authors: Thomas A Mitchell; Maryanne C Herzig; Chriselda G Fedyk; Marc A Salhanick; Aaron T Henderson; Bijaya K Parida; Nicolas J Prat; Daniel L Dent; Martin G Schwacha; Andrew P Cap Journal: Shock Date: 2017-06 Impact factor: 3.454
Authors: Matthew E Kutcher; Brittney J Redick; Ryan C McCreery; Ian M Crane; Molly D Greenberg; Leslie M Cachola; Mary F Nelson; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2012-07 Impact factor: 3.313
Authors: Martin Sillesen; Pär I Johansson; Lars S Rasmussen; Guang Jin; Cecilie H Jepsen; Ayehsa M Imam; John Hwabejire; Jennifer Lu; Michael Duggan; George Velmahos; Marc deMoya; Hasan B Alam Journal: J Trauma Acute Care Surg Date: 2013-05 Impact factor: 3.313
Authors: Lauren Shih; David Kaplan; Larry W Kraiss; T Charles Casper; Robert C Pendleton; Christopher L Peters; Mark A Supiano; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina Journal: Sci Rep Date: 2016-06-07 Impact factor: 4.379
Authors: Tessa J Barrett; MacIntosh Cornwell; Khrystyna Myndzar; Christina C Rolling; Yuhe Xia; Kamelia Drenkova; Antoine Biebuyck; Alexander T Fields; Michael Tawil; Elliot Luttrell-Williams; Eugene Yuriditsky; Grace Smith; Paolo Cotzia; Matthew D Neal; Lucy Z Kornblith; Stefania Pittaluga; Amy V Rapkiewicz; Hannah M Burgess; Ian Mohr; Kenneth A Stapleford; Deepak Voora; Kelly Ruggles; Judith Hochman; Jeffrey S Berger Journal: Sci Adv Date: 2021-09-08 Impact factor: 14.136
Authors: Pieter H Sloos; Paul Vulliamy; Cornelis van 't Veer; Anirban Sen Gupta; Matthew D Neal; Karim Brohi; Nicole P Juffermans; Derek J B Kleinveld Journal: Transfusion Date: 2022-06-24 Impact factor: 3.337